accountMerck beat top-line estimates as it enjoys the benefits of Singulair, its blockbuster drug that raked inn more than $1 billion this quarter.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Merck Beats As Singulair Rakes In The Cash, But Patents Expire Soon
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account